Encapsulated papillary carcinoma of the breast clinicopathological features and management: Could sentinel lymph node biopsy be exempted?

被引:0
|
作者
Ozcan, Cumhur [1 ]
Dag, Ahmet [1 ]
Benli, Sami [2 ]
Tuncel, Ferah [3 ]
机构
[1] Mersin Univ 33343 Yenisehir Mersin Turkey, Fac Med, Dept Gen Surg, Ciftlikkoy Campus, TR-33343 Yenisehir, Mersin, Turkiye
[2] Mersin Univ, Dept Surg Oncol, Fac Med, Mersin, Turkiye
[3] Mersin Univ, Fac Med, Dept Med Pathol, Mersin, Turkiye
关键词
breast cancer; Encapsulated papillary carcinoma; sentinel lymph node biopsy; LESIONS;
D O I
10.1111/ajco.14090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPapillary lesions in the breast pose diagnostic and therapeutic challenges. Encapsulated papillary carcinoma (EPC) is a rare breast cancer. However, evidence-based guidelines are limited. For this reason, there is no complete clarity in diagnosis and treatment management, and there are insufficient studies in the literature. This study aimed to examine the necessity of sentinel lymph node sampling in the management of EPC, in line with patients' clinicopathological data.MethodsWe retrospectively screened patients with EPC in our clinic between January 2012 and March 2022. We recorded and statistically evaluated patients' demographic, clinical, radiological, pathological, and treatment management.ResultsSixty-four patients with EPCs were identified. The final pathologic evaluation revealed that 19 patients (18.7%) had pure EPC, 27 patients (43.7%) had EPC with associated ductal carcinoma in situ and 18 patients (37.5%) had EPC associated with invasion. The mean age was 61 years, and two patients were male. Breast-conserving surgery was performed in 62 patients, and simple mastectomy was performed in two patients. Sentinel lymph node biopsy (SLNB) was positive in only one patient. Sixty-three patients with EPC were hormone receptor-positive, and one patient was triple-negative and was associated with invasion. None of the patients died, one had a local recurrence, and a mastectomy was performed.ConclusionsThe overall prognosis and long-term survival of patients with EPC were excellent. Our study and the current literature indicate that routine SLNB is overtreatment because surgical excision with negative margins is sufficient in EPC cases and lymph node metastasis is rare, even with an invasive component. The overall prognosis and long-term survival of EPC is excellent. Our study and currentliterature indicate routine SLNB is overtreatment since surgical excision with negative marginsis sufficient in EPC cases, and lymph node metastasis is rare, even with an invasive component. image
引用
收藏
页码:232 / 237
页数:6
相关论文
共 50 条
  • [11] Radioguided sentinel lymph node biopsy in patients with papillary thyroid carcinoma
    Portinari, Mattia
    Carcoforo, Paolo
    GLAND SURGERY, 2016, 5 (06) : 591 - 602
  • [12] Sentinel lymph node biopsy in papillary breast cancer; to do or not to do?
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (03): : 1665 - 1666
  • [13] The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes
    Yan, Xingqiang
    Zeng, Ruichao
    Ma, Zhaosheng
    Chen, Chengze
    Chen, Endong
    Zhang, Xiaohua
    Cao, Feilin
    PLOS ONE, 2015, 10 (06):
  • [14] Sentinel lymph node biopsy in clinically node negative patients with papillary thyroid carcinoma
    Markovic, Ivan
    Goran, Merima
    Buta, Marko
    Stojiljkovic, Dejan
    Zegarac, Milan
    Milovanovic, Zorka
    Dzodic, Radan
    JOURNAL OF BUON, 2020, 25 (01): : 376 - 382
  • [15] Infiltrating micropapillary carcinoma of the breast and sentinel lymph node biopsy
    Martinez, M. Angeles.
    Tresserra, Francisco
    Feu, Jaume
    Lopez-Marin, Luciano
    Fabregas, Rafael
    Izquierdo, Maximo
    VIRCHOWS ARCHIV, 2008, 452 : S132 - S133
  • [16] Sentinel lymph node biopsy: Beyond melanoma and breast carcinoma
    McMasters, KM
    CANCER, 2003, 97 (09) : 2134 - 2136
  • [17] Sentinel lymph node biopsy in patients with male breast carcinoma
    Port, ER
    Fey, JV
    Cody, HS
    Borgen, PI
    CANCER, 2001, 91 (02) : 319 - 323
  • [18] Sentinel lymph node biopsy in Breast ductal carcinoma "in situ"
    Sampol, C.
    Gimenez, M.
    Torrecabota, J.
    Pena, C.
    Serra, C.
    Hernandez, E.
    Canet, R.
    Pozo, A.
    Graner, A.
    Serra, F.
    Galmes, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S474 - S474
  • [19] Value of Sentinel Lymph Node Biopsy in Carcinoma in Situ of the Breast
    Sanz-Viedma, S.
    Moya-Espinosa, P.
    Sanchez-Munoz, A.
    Scholz-Gutierrez, V.
    Fernandez-Garcia, F.
    Ramos-Moreno, E.
    Martinez del Valle, M.
    Ortega Lozano, S.
    Alba, E.
    Jimenez-Hoyuela, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S125 - S125
  • [20] The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma
    Jaderborg, JM
    Harrison, PB
    Kiser, JL
    Maynard, SL
    AMERICAN SURGEON, 1999, 65 (08) : 699 - 703